PT  - JOURNAL ARTICLE
AU  - Gola, Abhinav
AU  - Arya, Ravi Kumar
AU - Animesh
AU  - Dugh, Ravi
AU  - Khan, Zuber
TI  - Fine-tuned Forecasting Techniques for COVID-19 Prediction in India
AID  - 10.1101/2020.08.10.20167247
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.10.20167247
4099  - http://medrxiv.org/content/early/2020/08/13/2020.08.10.20167247.short
4100  - http://medrxiv.org/content/early/2020/08/13/2020.08.10.20167247.full
AB  - Estimation of statistical quantities plays a cardinal role in handling of convoluted situations such as COVID-19 pandemic and forecasting the number of affected people and fatalities is a major component for such estimations. Past researches have shown that simplistic numerical models fare much better than the complex stochastic and regression-based models when predicting for countries such as India, United States and Brazil where there is no indication of a peak anytime soon. In this research work, we present two models which give most accurate results when compared with other forecasting techniques. We performed both short-term and long-term forecasting based on these models and present the results for two discrete durations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A